Metabolica 4‑cresol Pharmaceutical
Type 2 Diabetes, Obesity, NAFLD/NASH
PreclinicalActive
Key Facts
About Metabolica Health
Microbiome‑driven 4‑cresol platform targeting regenerative metabolic disease.
View full company profileType 2 Diabetes, Obesity, NAFLD/NASH
Microbiome‑driven 4‑cresol platform targeting regenerative metabolic disease.
View full company profile